Get the Stockscreener App
20.18
0.95%
-0.19
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $20.18, with a volume of 2.70M.
It is down -0.95% in the last 24 hours and up +5.91% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$20.37
Open:
$20.2
24h Volume:
2.70M
Relative Volume:
0.33
Market Cap:
$10.37B
Revenue:
$10.89B
Net Income/Loss:
$-241.00M
P/E Ratio:
-75.98
EPS:
-0.2656
Net Cash Flow:
$340.00M
1W Performance:
-4.24%
1M Performance:
+5.91%
6M Performance:
-28.88%
1Y Performance:
-34.81%
1-Day Range:
$20.05
$20.41
1-Week Range:
$19.36
$21.03
52-Week Range:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.18 | 10.47B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
536.47 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
208.42 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.54 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.56 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.51 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $23, Maintains Neutral Rating - marketscreener.com
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety - The Globe and Mail
Manning & Napier Advisors LLC Sells 51,029 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Baxter CEO outlines plan to slash debt, boost pipeline in 2026 - Crain's Chicago Business
Baxter International Inc. Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in HospitalSettings - marketscreener.com
BaxterDynamo series is now available for order in the U.S. and is expected to be available during the first half of 2026 - marketscreener.com
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Rutland Herald
Baxter Introduces the Dynamo Series, A New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Baxter
Does Baxter International (BAX) Now Look Fairly Priced After Multi‑Year Share Price Slide - Yahoo Finance
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Why Baxter (BAX) Stock Is Trading Lower Today - The Globe and Mail
Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside - DirectorsTalk Interviews
Stock Traders Buy Large Volume of Baxter International Put Options (NYSE:BAX) - MarketBeat
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges - Bioscience Association Manitoba
The Truth About Baxter International Inc.: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
SG Americas Securities LLC Grows Stock Holdings in Baxter International Inc. $BAX - MarketBeat
Barclays Cuts Baxter International (NYSE:BAX) Price Target to $30.00 - MarketBeat
Barclays Adjusts Price Target on Baxter International to $30 From $36, Maintains Overweight Rating - marketscreener.com
Baxter International Inc.: How a 90-Year Medtech Veteran Is Rebuilding Its Flagship Portfolio - AD HOC NEWS
A Look At Baxter International (BAX) Valuation After New MUSC Health Connected Care Partnership - Sahm
Why Baxter International Inc. stock is in analyst buy zoneJuly 2025 Reactions & Community Trade Idea Sharing Platform - ulpravda.ru
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Price Swings & Safe Capital Investment Plans - ulpravda.ru
Breakout Move: Can Baxter International Inc. stock attract ESG capital inflowsJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - ulpravda.ru
Will Baxter International Inc. stock outperform Nasdaq index2025 Major Catalysts & AI Optimized Trading Strategy Guides - ulpravda.ru
How strong is Baxter International Inc. stock revenue growthJuly 2025 WrapUp & AI Driven Price Predictions - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology - Investing.com Australia
Is Baxter International Inc. stock vulnerable to regulatory risksExit Point & Fast Moving Market Watchlists - ulpravda.ru
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address - PharmiWeb.com
Baxter partnership - The Medical University of South Carolina
Signal Recap: Can Baxter International Inc. stock weather global recession2025 Price Targets & High Win Rate Trade Alerts - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology By Investing.com - Investing.com South Africa
Will Baxter International Inc. stock see insider accumulationTrade Entry Summary & High Return Trade Guides - ulpravda.ru
Fund Update: 4,404,874 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Baxter to Present at J.P. Morgan 2026 Healthcare Conference - MarketScreener
New fraud claims filed in federal lawsuits against IV pump company - KMOV
Baxter International (NYSE:BAX) Given New $23.00 Price Target at Evercore ISI - MarketBeat
How to watch Baxter’s CEO at the 2026 J.P. Morgan healthcare conference - Stock Titan
The Truth About Baxter International (NYSEreplacing with BCRX): Is This Biotech Underdog About To - AD HOC NEWS
Evercore ISI Adjusts Price Target on Baxter International to $23 From $24 - marketscreener.com
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $24 - 富途牛牛
Artisan Mid Cap Value Fund’s Views on Baxter International (BAX) - Insider Monkey
How Investors Are Reacting To Baxter (BAX) Debt Tender Offers And Smart Infusion EMR Data - simplywall.st
Assessing Baxter International (BAX) Valuation After Recent Share Price Momentum And Margin Concerns - Yahoo Finance
How Investors May Respond To Baxter (BAX) Retiring Near‑Term Debt And Advancing Connected Infusion Therapy - Yahoo Finance
The Truth About Baxter International Inc.: Is This ‘Boring’ Stock a Secret Power Play? - AD HOC NEWS
Baxter International (BAX) and Vaneck Gold Miners ETF (GDX) top the Bull Strangle watch list for next week - Barchart.com
Baxter International Inc Stock Price Live, Charts & News - The Economic Times
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What do analysts think about Baxter International Inc. (BAX)? - MSN
What Do Analysts Think About Baxter International Inc. (BAX)? - Insider Monkey
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):